Advertisement
Screener

bioAffinity Technologies, Inc. (BIAF) Form D

bioAffinity Technologies, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2017-07-26: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-07-11; Total offering amount $4,047,993.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2017-07-26Rule 506(b)Equity2017-07-11$4,047,993$4,047,993$039

Similar stocks

Stock NameCountryMarket CapPE Ratio
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14